Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Disposable Aseptic Isolation Systems Market size was valued at USD 1.33 billion in 2024 and is likely to cross USD 2.8 billion by 2037, expanding at more than 5.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of disposable aseptic isolation systems is estimated at USD 1.4 billion.
The growth of the market can be attributed to the increase in production and employment in healthcare services. As per the U.S Bureau of Labor Statistics, total employment is estimated to raise up to 16% over the decade (2020-2030) with an increase of 2.6 million jobs. Additionally, the introduction of the latest products, technological advancements, and innovations in disposable aseptic isolation systems impacted the growth of the market.
Further, the increased implementation of safe and contamination-free drugs during COVID-19 has created numerous growth opportunities for the disposable aseptic isolation systems market. Companies in the field of aseptic isolator systems took the opportunity to produce more products and increase the availability of their products thus increasing the market growth. Additionally, the increase in the contribution made by the biopharmaceutical industry in the development of the world’s healthcare sector is projected to upsurge the market growth. The worldwide sales of biopharmaceutical products had shown a drastic growth in value from around USD 100 in 2001 to USD about 600 in 2018.
Disposable Aseptic Isolation Systems Sector: Growth Drivers and Challenges
Growth Drivers
- Increase in Bio Pharmacy Industry – As per IFPMA 23 biopharmaceutical companies, in July 2020 partnered with non-governmental stakeholders to develop 4 novel antibiotics by launching USD 1 billion AMR (Anti-Microbial Resistance) Action Fund.
- Rising Use of Vaccines- According to Our World in Data 67.4% of the world population has received one dose of the COVID-19 vaccine. Globally, 12.47 billion doses have been administered and 5.05 million are now being administered each day.
- Increase in Research Labs - As per aggregate estimates of about 60 companies, the investment of the private sector for R&D dedicated to AMR-related products was more than USD 2 billion in 2018.
- Rise of COVID-19 – The COVID-19 vaccine output reached about 13 billion doses by the end of 2021 and is estimated to reach 25 billion by mid-2022.
- Increase Deaths from Contaminated Products – Nitrosamines, potent carcinogens are found as an impurity in medications such as ranitidine, nizatidine, ARBs, metformin, and other OTC drugs.
Challenges
- Higher Purchase Costs – Current health expenditure across the world was 10 (% of GDP) in 2019, up from 9 in 2017.
- Limited Flexibility
- Lack of Sanitation Awareness in Low-Income Countries – According to a report by UNICEF, in 2020, 2.3 billion lack basic sanitation services.
Disposable Aseptic Isolation Systems Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.9% |
|
Base Year Market Size (2024) |
USD 1.33 billion |
|
Forecast Year Market Size (2037) |
USD 2.8 billion |
|
Regional Scope |
|
Disposable Aseptic Isolation Systems Segmentation
The global disposable aseptic isolation systems market is segmented and analyzed for demand and supply by end-user into pharmaceutical companies, hospitals, chemical industry, research institutes, biosafety laboratories, and others. Out of which, the pharmaceutical companies segment is anticipated to hold the largest market size by the end of 2031 on account of growing demand for pharmaceutical isolators in the pharmaceutical and biotechnological industries during the forecast period. Moreover, the increasing regulations, usage of aseptic methods, growing research laboratories, cost of noncompliance, rising usage of harmful materials, and advancements in the efficiency of isolators are expected to be major growth factors. The research and development expenditure (in GDP %) in 2021 amounted to 2.63% up from 2.13% in 2017.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportDisposable Aseptic Isolation Systems Industry - Regional Synopsis
Regionally, the global disposable aseptic isolation systems market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is poised to account for largest revenue share by 2037, attributed to great hold in the dominating position of the manufacturing industry, adoption of disposable aseptic isolation systems in the field of biopharmaceuticals, and rise of investment in medicines and healthcare. As per the IFMA report 2021, the global spending of the United States on medicines will increase from USD 485 billion in 2018 to USD 625-655 billion in 2023.
Companies Dominating the Global Disposable Aseptic Isolation Systems Landscape
- Arjo Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Famed Zywiec Sp. z o. o.
- GF Health Products, Inc.
- Getinge AB
- Hillrom Company Inc.
- Invacare Corporation
- LINET spol.s r.o.
- Malvestio Spa
- Merivaara Corporation
- Midmark Corporation
In the News
-
Berkshire Sterile Manufacturing introduced a new technology to decontaminate RTU tubs for sterility assurance during filling operations thereby reducing the risk of contamination.
-
Getinge AB provides at-home care for cancer patients in coordination with Sciensus. They together made GMP ISOFLEX-R aseptic isolators with a DPTE transfer system that uses RTP or alpha-beta transfer port with no leakage and risk-free connectivity.
Author Credits: Radhika Pawar
- Report ID: 4267
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT
